Home | Medical-Newswire.Com:
(Medical-NewsWire.com, April 16, 2018 ) The Europe nuclear medicine diagnostic market is estimated at $2.36 billion in 2015 and is expected to reach $4.08 billion by 2020, at a compound annual growth rate (CAGR) of 11.60%.Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most cases, the information will assist the physicians to make a quick, accurate diagnosis of the patient's illness.
Browse Full Report with TOC @ https://marketdataforecast.com/market-reports/europe-nuclear-medicine-diagnostics-market-125/
Till today, SPECT imaging was the most conventional modality for nuclear medicine applications such as nuclear cardiology procedures. However, the trend is soon going to see a down turn owing to shortage of molybdenum-99 isotope which is in turn will lead to deficiency of Technetium-99, which is the by-product of molybdenum. Therefore, PET imaging products which include hybrid PET-CT scanners is expected to account for a potentially hefty market size in the near future.
The emerging market will be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET. This provides full range of imaging scans through the same unit and at the same time. PET market is expected to witness faster growth compared to SPECT imaging as it delivers higher resolution images. Lack of availability of technetium-99m is also forcing the industry to look for alternative diagnostic procedures
Get Free Sample Copy of Report @ https://marketdataforecast.com/market-reports/europe-nuclear-medicine-diagnostics-market-125/request-sample
Increasing usage of SPECT and PET in medical diagnostics, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are some of the major factors driving the growth of the market. However, shorter half- life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are the key factors restraining the market growth.
The Nuclear Medicine Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others) and PET (Rubidium-82 (RB-82), Fluorine-18, and others). By application,the market is categorized into SPECT (lymphoma, cardiology,neurology,thyroid and others) and PET(cardiology,oncology, neurology and others).
Browse Customize before buying @ https://marketdataforecast.com/market-reports/europe-nuclear-medicine-diagnostics-market-125/customize-report
Nuclear Medicine Diagnostic Market Segmentation:
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Name: Mr. Abhishek Shukla
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Market Data Forecast.